Company
Funding data: Recent Funding. Each amount links to the announcement it came from.
OpenEvidence
OpenEvidence is a next-generation AI platform transforming how healthcare professionals and organizations access and apply medical information. Built on cutting-edge large language models and deep clinical data, OpenEvidence enables faster, more reliable, and more personalized decision-making for clinicians and life sciences partners.
Rounds
| Date | Stage | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Sep 24, 2026 | Series B+ | $250M | $15B | Andreessen Horowitz, hospital systems | refreshmiami.com ↗ |
| Jan 21, 2026 | Series B+ | $250M | $12B | — | techcrunch.com ↗ |
| Oct 20, 2025 | Series B+ | $200M | $6B | — | techcrunch.com ↗ |
| Jul 15, 2025 | Series B+ | $210M | $3.5B | — | finsmes.com ↗ |
| Feb 20, 2025 | Series A | $75M | $1B | — | axios.com ↗ |
About
- Website
- openevidence.com
- X
- @OpenEvidence
- Based in
- Cambridge, United States
- Founded
- 2021
Founders
- Daniel NadlerFounder
- Zachary ZieglerFounder
Investors
Andreessen Horowitz · Blackstone · BOND · Breyer Capital · Byers Capital · Catalio · Coatue · Conviction · Craft Ventures · DST Global · GV · hospital systems · Irving Investors · Kleiner Perkins · Mayo Clinic · Nvidia · Sequoia · Thrive Capital
On GitHub
0 stars across its repos · linked because its GitHub profile's website is openevidence.com